Ev3 adds to embolic product portfolio in Chestnut takeover
Endovascular device firm ev3 has acquired privately held Chestnut Medical Technologies (neurointerventional surgery) for $75mm up front plus another $75mm in potential regulatory earn-outs.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Full Acquisition
- Includes Contract
- Includes Earnout
- Payment Includes Cash for Equity
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.